JEADV Clinical Practice

Startseite
Schweiz
Lugano
JEADV Clinical Practice

JEADV Clinical Practice is EADV’s new open access journal and the companion title to the highly-regarded JEADV.

JEACP features cutting-edge clinical, educational and patient-centered content.

29/05/2026

In this contribution, Traini et al. describe the case of a 58-year-old patient with erythematous atrophic plaques who underwent LC-OCT imaging, revealing skin abnormalities suggestive of mycosis fungoides.

A targeted biopsy confirmed the diagnosis at the plaque stage. The report highlights the potential of LC-OCT to improve diagnostic accuracy and optimize biopsy site selection in challenging dermatological cases.

Discover more 👉 https://bit.ly/4nEPi1n

27/05/2026

𝗤𝘂𝗶𝘇 𝘁𝗶𝗺𝗲!

A 70-year-old man with a history of extensive travel to South and Southeast Asia presents with diffuse erythematous plaques, nodules, and hyperkeratotic lesions on the trunk, limbs, face, and earlobes, alongside progressive peripheral neuropathy and unexplained weight loss.

🤔 What's the diagnosis?

22/05/2026

This case report by Dixit et al. describes a 53-year-old woman with necrobiotic xanthogranuloma (NXG) associated with IgG lambda monoclonal gammopathy of undetermined significance (MGUS), presenting with progressive cutaneous and ocular involvement. Given the lack of standardized therapies for NXG, pegylated interferon alpha-2a (PEG-IFN-α-2a) was initiated as first-line treatment.

The patient showed significant clinical improvement and reduction of paraproteinemia at a low weekly dose, with manageable side effects. The case suggests that PEG-IFN-α-2a may be a promising and well-tolerated therapeutic option for progressive NXG in patients with MGUS.

Find out more 👉 https://bit.ly/4sdU9HT

20/05/2026

Can a cyst hide a molluscum infection?

A short report by Sánchez Cárdenas et al. documents 14 cases of molluscum contagiosum (MCV) within epidermoid cysts, stressing that only histology can reliably reveal this unexpected combination.

Find out more 👉 https://bit.ly/4qLCg2L

15/05/2026

Could dupilumab treat pemphigus? A case report by Mateos Rico et al. shows a patient with severe pemphigus vulgaris (PV) achieving complete remission after 6 months on dupilumab.

The study suggests it may be a viable therapeutic alternative when standard treatments are contraindicated or poorly tolerated.

Full details 👉 https://bit.ly/4qPcMld

13/05/2026

A 13-year-old male presented with diffuse, pruritic plaques and patches of alopecia with fine scaling on the scalp. Discrete pustules and broken hairs were also noted. Dermoscopy revealed coiled corkscrew-shaped, comma-shaped, and zigzag hairs, along with scales, crusts, and black dots.

❓How would you treat this condition?

𝗔. Oral antifungals for 4 weeks, along with topical antifungals and shampoo

𝗕. Topical corticosteroids

𝗖. Topical antibiotics

🩺 Challenge yourself with our , originally proposed by Dr Prajwal Pudasaini, MD Dermatology

Many thanks to Dr. Pudasaini for the creation of this stimulating quiz and for contributing significantly to our knowledge-sharing initiative!

08/05/2026

Empowering psoriasis patients through social media: Ngo et al. demonstrate that personalized Facebook messages improve treatment adherence, boost disease knowledge, and enhance quality of life, pointing to an accessible, low-cost support model.

Full article 👉 https://bit.ly/4t9xL3O

06/05/2026

A rare paraneoplastic duo: Amat Sánchez et al. report concurrent florid oral papillomatosis (FOP) and malignant acanthosis nigricans (MAN) in a patient with HPV 16 positive carcinoma of unknown primary.

This case highlights that cutaneous signs may reflect occult malignancy, especially under immunotherapy.

Discover more 👉 https://bit.ly/4bSSMJE

01/05/2026

Could AI replace the psoriasis PASI score?

Research by Mac Carthy et al. shows APASI, an automated scoring system, matches expert dermatologist performance, offering a more objective, rapid, and cost-effective way to monitor treatment.

Dive in 👉 https://bit.ly/4qPLVWi

29/04/2026

A histological study by Kemanetzi et al. examines checkpoint inhibitor-induced skin rashes (cirAEs).

Results indicate that eczematoid, psoriasiform, lichenoid, and BP-like reactions share key features with their idiopathic forms, reinforcing the importance of clinicopathologic correlation in ambiguous cases.

Full details 👉 https://bit.ly/3NIsBvh

Adresse

Via S. Balestra 22B
Lugano
6900

Webseite

http://linktr.ee/jeacp

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von JEADV Clinical Practice erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.